Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of Begrivac influenza vaccine in healthy adults and elderly
2009-010565-23Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Agrippal S1 in influenza, sponsored by Novartis. Primary endpoint: Immunogenicity endpoints. Started Mar 2009; status: completed.
02
Drugs
Agrippal S1
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-010565-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010565-23.